Analyst Ratings for Cyclerion Therapeutics (CYCN)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/20/2021 | Truist Securities » Updated 5/5/2022 |
Joon Lee | New Coverage | Buy (N/A) |
14.00 (N/A) |
2.66 (1.41) |
-46.99% | Details |
| 9/24/2021 | Cantor Fitzgerald | N/A | New Coverage | Overweight (N/A) |
7.00 (N/A) |
3.49 (1.41) |
-59.6% | Details |
 |
||||||||
